The Role of Brain Norepinephrine in the Anorexic Effects of Dextroamphetamine and Monoamine Oxidase Inhibitors in the Rat

Overview

Journal Psychopharmacologia

Specialty Pharmacology

Date 1971 Jan 1

PMID 5124188

Citations 11

Authors

S G Holtzman

R E JEWETT

Affiliations

Soon will be listed here.

Citing Articles

Past, Present and Future Anti-Obesity Effects of Flavin-Containing and/or Copper-Containing Amine Oxidase Inhibitors.

Carpene C, Boulet N, Chaplin A, Mercader J Medicines (Basel). 2019; 6(1).

PMID: 30650583 PMC: 6473341. DOI: 10.3390/medicines6010009.

The antidepressant trans-2-phenylcyclopropylamine protects mice from high-fat-diet-induced obesity.

Shemesh A, Abdulla A, Yang F, Chua S, Pessin J, Zong H PLoS One. 2014; 9(2):e89199.

PMID: 24586592 PMC: 3931726. DOI: 10.1371/journal.pone.0089199.

Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs.

Cousins M, Wei W, Salamone J Psychopharmacology (Berl). 1994; 116(4):529-37.

PMID: 7701059 DOI: 10.1007/BF02247489.

Dissociable effects of 6-OHDA-induced lesions of neostriatum on anorexia, locomotor activity and stereotypy: the role of behavioural competition.

Joyce E, Iversen S Psychopharmacology (Berl). 1984; 83(4):363-6.

PMID: 6436865 DOI: 10.1007/BF00428546.

Role of catecholamines in the anorectic effects of amphetamine in rats.

Baez L Psychopharmacologia. 1974; 35(2):91-8.

PMID: 4815118 DOI: 10.1007/BF00429576.

References

Spector S . Monoamine oxidase in control of brain serotonin and norepinephrine content. Ann N Y Acad Sci. 1963; 107:856-64. DOI: 10.1111/j.1749-6632.1963.tb13329.x. View

ANTON A, SAYRE D . A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther. 1962; 138:360-75. View

RANDRUP A, MUNKVAD I, UDSEN P . ADRENERGIC MECHANISMS AND AMPHETAMINE INDUCED ABNORMAL BEHAVIOUR. Acta Pharmacol Toxicol (Copenh). 1963; 20:145-57. DOI: 10.1111/j.1600-0773.1963.tb01731.x. View

Moore K, LARIVIERE E . EFFECTS OF D-AMPHETAMINE AND RESTRAINT ON THE CONTENT OF NOREPINEPHRINE AND DOPAMINE IN RAT BRAIN. Biochem Pharmacol. 1963; 12:1283-8. DOI: 10.1016/0006-2952(63)90196-5. View

Stein L . SELF-STIMULATION OF THE BRAIN AND THE CENTRAL STIMULANT ACTION OF AMPHETAMINE. Fed Proc. 1964; 23:836-50. View

Spector S, SJOERDSMA A, UDENFRIEND S . BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE. J Pharmacol Exp Ther. 1965; 147:86-95. View

MODELL W . Status and prospect of drugs for overeating. JAMA. 1960; 173:1131-6. DOI: 10.1001/jama.1960.73020280008015. View

Weiss B, Laties V . Behavioral pharmacology and toxicology. Annu Rev Pharmacol. 1969; 9:297-326. DOI: 10.1146/annurev.pa.09.040169.001501. View

SOULAIRAC A . The adrenergic and cholinergic control of food and water intake. Ann N Y Acad Sci. 1969; 157(2):934-61. DOI: 10.1111/j.1749-6632.1969.tb12929.x. View

10.

Borella L, Paquette R, Herr F . The effect of some CNS depressants on the hypermotility and anorexia induced by amphetamine in rats. Can J Physiol Pharmacol. 1969; 47(10):841-7. DOI: 10.1139/y69-140. View

11.

Pletscher A . Monoamine oxidase inhibitors. Pharmacol Rev. 1966; 18(1):121-9. View

12.

Ansell G, Beeson M . A rapid and sensitive procedure for the combined assay of noradrenaline, dopamine AND SEROTONIN IN A SINGLE BRAIN SAMPLE. Anal Biochem. 1968; 23(2):196-206. DOI: 10.1016/0003-2697(68)90351-5. View

13.

Weissman A, KOE B, TENEN S . Antiamphetamine effects following inhibition of tyrosine hydroxylase. J Pharmacol Exp Ther. 1966; 151(3):339-52. View

14.

Carlsson A, Fuxe K, Hamberger B, Lindqvist M . Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta Physiol Scand. 1966; 67(3):481-97. DOI: 10.1111/j.1748-1716.1966.tb03334.x. View